| Filing Date | Form | Description | Issuer | View |
|---|---|---|---|---|
| 8-K | Report of unscheduled material events or corporate event | Intellia Therapeutics, Inc. | ||
| 10-Q | Quarterly report which provides a continuing view of a company's financial position | Intellia Therapeutics, Inc. | ||
| SCHEDULE 13G | SCHEDULE 13G - Description | Intellia Therapeutics, Inc. | ||
| DEF 14A | Official notification to shareholders of matters to be brought to a vote ("Proxy") | Intellia Therapeutics, Inc. | ||
| DEFA14A | Additional proxy soliciting materials - definitive | Intellia Therapeutics, Inc. | ||
| ARS | An annual report to security holders | Intellia Therapeutics, Inc. | ||
| 8-K | Report of unscheduled material events or corporate event | Intellia Therapeutics, Inc. | ||
| SCHEDULE 13G | SCHEDULE 13G - Description | Intellia Therapeutics, Inc. | ||
| 424B5 | Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3 | Intellia Therapeutics, Inc. | ||
| 8-K | Report of unscheduled material events or corporate event | Intellia Therapeutics, Inc. |
Displaying 1 - 10 of 696 results
Data provided by Kaleidoscope.